Eli Lilly said it plans to roll out a half-price version of its Humalog insulin, an effort that comes amid rising scrutiny and criticism over the surging cost of the life-saving medication. The price ...

(AP) — Eli Lilly is offering a half-price version of a top-selling insulin to ease the financial strain for some patients, but an advocacy group says much bigger changes are needed. The drugmaker said ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...

The change comes on the heels of hearings in Congress where insulin costs were held up for scrutiny. Eli Lilly, under fire for soaring insulin prices, today announced it will introduce an “authorized ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

The FDA recently approved a 200 units/mL Humalog KwikPen, a pre-filled, rapid-acting insulin pen designed to improve glycemic control in people with type 1 and type 2 diabetes, Eli Lilly and Company ...

Eli Lilly has faced no shortage of trouble in diabetes recently, but the company now faces a new threat from rival Sanofi. The latter company won tentative FDA approval for a biosimilar to Lilly’s ...

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. The moves announced Wednesday promise critical ...

Eli Lilly and Company announced the launch of Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL [U-200]). Eli Lilly and Company announced the launch of Humalog 200 units/mL KwikPen (insulin ...

This month, Eli Lilly and Co. announced with some fanfare that it was manufacturing a generic version of its own best-selling insulin brand, Humalog, which it would sell for half off — $137.35 versus ...